Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Rebeccamycin Analogue in Treating Children With Solid Tumors or Non-Hodgkin's Lymphoma
This study has been completed.
Study NCT00006102 Information provided by National Cancer Institute (NCI)
First Received: August 3, 2000 Last Updated: February 17, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lymphoma
Neuroblastoma
Retinoblastoma
Sarcoma
Additional conditions recognized in this trial
Central Nervous System Neoplasms
Lymphoma, Non-Hodgkin
Neoplasms
Nervous System Neoplasms
More general conditions related to this trial
Eye Diseases
Eye Neoplasms
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Nervous System Diseases
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Neuroectodermal Tumors, Primitive, Peripheral
Retinal Diseases
Retinal Neoplasms
Interventions listed in this trial
becatecarin
Sponsors listed in this trial
Children's Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
